Intraductal meibomian gland probing reduces inflammation

A five-step approach to personalise and simplify treatment, leading to higher efficacy

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease

The authors examined vascular and neural structures in the eye, assessing the foveal avascular zone and choroidal thickness